JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5076
Tenaya Therapeutics
TNYA
$168M
| $232K | ﹤0.01% |
12,229
+5,503
| +82% | +$120K |
|
5077
Universal Logistics Holdings
ULH
$514M
| $231K | ﹤0.01% |
12,286
+5,868
| +91% | +$116K |
|
5078
First Trust Indxx NextG ETF
NXTG
$579M
| $230K | ﹤0.01% |
2,781
+1,265
| +83% | +$101K |
|
5079
United States Natural Gas Fund
UNG
$495M
| $230K | ﹤0.01% |
4,601
+901
| +24% | +$58.6K |
|
|
MYOV
5080
DELISTED
Myovant Sciences Ltd.
MYOV
| $230K | ﹤0.01% |
14,828
+1,360
| +10% | +$26K |
|
5081
Boston Omaha
BOC
$418M
| $229K | ﹤0.01% |
7,989
+1,231
| +18% | +$40.2K |
|
5082
Gaia
GAIA
$35.3M
| $229K | ﹤0.01% |
26,688
+1,458
| +6% | +$13.6K |
|
|
DOMA
5083
DELISTED
Doma Holdings, Inc.
DOMA
| $229K | ﹤0.01% |
1,796
-18,419
| -91% | -$2.85M |
|
5084
Grupo Aeroportuario Centro Norte
OMAB
$5.14B
| $228K | ﹤0.01% |
4,249
-3,686
| -46% | -$184K |
|
5085
argenx
ARGX
$52.6B
| $227K | ﹤0.01% |
649
-217
| -25% | -$66K |
|
5086
Lee Enterprises
LEE
$183M
| $227K | ﹤0.01% |
6,601
+1,080
| +20% | +$27.4K |
|
|
OPNT
5087
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $227K | ﹤0.01% |
6,743
+5,584
| +482% | +$156K |
|
|
AVDL
5088
DELISTED
Avadel Pharmaceuticals
AVDL
| $225K | ﹤0.01% |
27,862
-220,602
| -89% | -$2.02M |
|
5089
Nathan's Famous
NATH
$397M
| $225K | ﹤0.01% |
3,850
+2,146
| +126% | +$131K |
|
5090
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.25B
| $225K | ﹤0.01% |
2,420
-1,252
| -34% | -$114K |
|
5091
Verrica Pharmaceuticals
VRCA
$85.6M
| $225K | ﹤0.01% |
2,459
-592
| -19% | -$67K |
|
5092
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.24B
| $224K | ﹤0.01% |
4,205
+2,705
| +180% | +$144K |
|
5093
Olema Pharmaceuticals
OLMA
$906M
| $224K | ﹤0.01% |
23,872
+6,354
| +36% | +$132K |
|
|
HTT
5094
High Templar Tech Ltd
HTT
$390M
| $223K | ﹤0.01% |
230,556
+13,791
| +6% | +$20K |
|
5095
Rhythm Pharmaceuticals
RYTM
$7.91B
| $223K | ﹤0.01% |
22,280
-221
| -1% | -$2.48K |
|
5096
Valhi
VHI
$458M
| $223K | ﹤0.01% |
7,738
+1,426
| +23% | +$36.5K |
|
|
ITI
5097
DELISTED
Iteris, Inc.
ITI
| $223K | ﹤0.01% |
55,840
+29,391
| +111% | +$142K |
|
5098
Flexsteel Industries
FLXS
$303M
| $222K | ﹤0.01% |
8,272
+2,785
| +51% | +$79.9K |
|
5099
Finance of America Companies
FOA
$204M
| $222K | ﹤0.01% |
5,596
+2,587
| +86% | +$123K |
|
|
QTNT
5100
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $222K | ﹤0.01% |
2,143
+829
| +63% | +$79.4K |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.